BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 8847559)

  • 1. Strategies for Improved Intra-arterial Treatments Targeting Brain Tumors: a Systematic Review.
    Huang R; Boltze J; Li S
    Front Oncol; 2020; 10():1443. PubMed ID: 32983974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose escalation study of intravenous and intra-arterial N-acetylcysteine for the prevention of oto- and nephrotoxicity of cisplatin with a contrast-induced nephropathy model in patients with renal insufficiency.
    Dósa E; Heltai K; Radovits T; Molnár G; Kapocsi J; Merkely B; Fu R; Doolittle ND; Tóth GB; Urdang Z; Neuwelt EA
    Fluids Barriers CNS; 2017 Oct; 14(1):26. PubMed ID: 28974245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study.
    Guillaume DJ; Doolittle ND; Gahramanov S; Hedrick NA; Delashaw JB; Neuwelt EA
    Neurosurgery; 2010 Jan; 66(1):48-58; discussion 58. PubMed ID: 20023537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined carboplatin and cisplatin. Limited prospects for dose intensification.
    Waterhouse DM; Reynolds RK; Natale RB
    Cancer; 1993 Jun; 71(12):4060-6. PubMed ID: 8508371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-arterial cisplatin in malignant brain tumors: incidence and severity of otic toxicity.
    Assietti R; Olson JJ
    J Neurooncol; 1996 Mar; 27(3):251-8. PubMed ID: 8847559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
    Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Schornagel JH; Dreschler WA; Rasch CR; Balm AJ
    J Clin Oncol; 2007 Aug; 25(24):3759-65. PubMed ID: 17704425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer.
    Frisina RD; Wheeler HE; Fossa SD; Kerns SL; Fung C; Sesso HD; Monahan PO; Feldman DR; Hamilton R; Vaughn DJ; Beard CJ; Budnick A; Johnson EM; Ardeshir-Rouhani-Fard S; Einhorn LH; Lipshultz SE; Dolan ME; Travis LB
    J Clin Oncol; 2016 Aug; 34(23):2712-20. PubMed ID: 27354478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-arterial cisplatin for the treatment of malignant gliomas.
    Newton HB; Page MA; Junck L; Greenberg HS
    J Neurooncol; 1989 May; 7(1):39-45. PubMed ID: 2547032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer.
    Madasu R; Ruckenstein MJ; Leake F; Steere E; Robbins KT
    Arch Otolaryngol Head Neck Surg; 1997 Sep; 123(9):978-81. PubMed ID: 9305250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profound hearing loss from intravertebral artery cisplatin.
    Wetmore SJ; Koike KJ; Bloomfield SM
    Otolaryngol Head Neck Surg; 1997 Feb; 116(2):234-7. PubMed ID: 9051071
    [No Abstract]   [Full Text] [Related]  

  • 12. A phase I study of intracarotid artery infusion of cis-Diamminedichloroplatinum(II) in patients with recurrent malignant intracerebral tumors.
    Stewart DJ; Wallace S; Feun L; Leavens M; Young SE; Handel S; Mavligit G; Benjamin RS
    Cancer Res; 1982 May; 42(5):2059-62. PubMed ID: 7199971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system.
    Greenberg HS; Ensminger WD; Chandler WF; Layton PB; Junck L; Knake J; Vine AK
    J Neurosurg; 1984 Sep; 61(3):423-9. PubMed ID: 6747681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase-I trial of intracarotid BCNU and cisplatin in patients with malignant intracerebral tumors.
    Feun LG; Wallace S; Yung WK; Lee YY; Leavens ME; Moser R; Savaraj N; Burgess MA; Plager C; Benjamin RS
    Cancer Drug Deliv; 1984; 1(3):239-45. PubMed ID: 6544123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraarterial cis-platinum chemotherapy for patients with primary and metastatic brain tumors.
    Lehane DE; Bryan RN; Horowitz B; DeSantos L; Ehni G; Zubler MA; Moiel R; Rudolph L; Aldama-Leubbert A; Mahoney D
    Cancer Drug Deliv; 1983; 1(1):69-77. PubMed ID: 6544119
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.